ENANTIA, S.L.U.
- CMO, CRO
- Synthesis, analytic, diagnostic services
- Other R&D services
Enantia is a Contract Research Organization offering services in Medicinal and Process Chemistry and Solid-State R&D. Our industry-leading reputation has been built with over 22 years of expertise and is backed up by over 90 patents where we appear as inventors.
We are pioneers in the use of cocrystals in process chemistry and as innovative final forms. This is reflected in Seglentis, an API·API cocrystal (Celecoxib and Tramadol·HCl) discovered at our facilities and approved by the FDA in 2021. Our solid-state R&D unit is equipped to work with Highly Potent APIs (HPAPIs) with OELs down to 100 ng/m3.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}